White Mark Andrew has filed 5 insider transactions across 1 company since February 2024.
Most recent transaction: a sale of 3080 shares of ROCKET PHARMACEUTICALS, INC. ($RCKT) on October 31, 2024.
Activity breakdown: 0 open-market purchases and 3 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct. 31, 2024 | ROCKET PHARMACEUTICALS, INC. | $RCKT | White Mark Andrew | See Remarks | S | Common Stock | 3080 | $16.63 | 69,140.0000 | 94,158,491 | 4.26% | 0.00% |
| July 8, 2024 | ROCKET PHARMACEUTICALS, INC. | $RCKT | White Mark Andrew | See Remarks | S | Common Stock | 3026 | $20.40 | 72,220.0000 | 84,009,004 | 4.02% | 0.00% |
| April 8, 2024 | ROCKET PHARMACEUTICALS, INC. | $RCKT | White Mark Andrew | See Remarks | S | Common Stock | 12532 | $24.64 | 75,226.0000 | 84,009,004 | 14.28% | 0.01% |
| Feb. 16, 2024 | ROCKET PHARMACEUTICALS, INC. | $RCKT | White Mark Andrew | Chief Medical Officer | A | Common Stock | 11096 | $0.00 | 87,758.0000 | 84,009,004 | 14.47% | 0.01% |
| Feb. 16, 2024 | ROCKET PHARMACEUTICALS, INC. | $RCKT | White Mark Andrew | Chief Medical Officer | A | Stock Option (Right to Buy) | 32727 | $0.00 | 32,727.0000 | 84,009,004 | 9999.99% | 0.04% |